IP Library Granted Patent US 7,323,314
Granted Patent B2
US 7,323,314 · App. 11/013,090 · Granted Jan 29, 2008

Members of the capsaicin/vanilloid receptor family of proteins and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,323,314
App. No.
11/013,090
Granted
Jan 29, 2008
Kind
B2
Abstract

The invention provides isolated nucleic acids molecules, designated hVR-1, hVR-2, and rVR-2 nucleic acid molecules, which encode novel members of the Capsaicin/Vanilloid receptor family. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing hVR-1, hVR-2, and rVR-2 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which an hVR-1, hVR-2, and rVR-2 gene has been introduced or disrupted. The invention still further provides isolated hVR-1, hVR-2, and rVR-2 proteins, fusion proteins, antigenic peptides and anti-hVR-1, anti-hVR-2, and anti-rVR-2 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.

Claims (28)

1. A method for identifying a compound which modulates the activity of a polypeptide comprising the amino acid sequence of SEQ ID NO:5, the method comprising:

a) contacting a cell expressing the polypeptide with a test compound; and

b) determining the effect of the test compound on the activity of the polypeptide, thereby identifying a compound which modulates the activity of the polypeptide.

2. The method of claim 1 , wherein the activity is a hVR-2 activity.

3. The method of claim 2 , wherein the hVR-2 activity is modulation of membrane depolarization.

4. The method of claim 2 , wherein the hVR-2 activity is modulation of intracellular calcium levels.

5. The method of claim 1 , wherein the cell expressing the polypeptide is a neuronal cell.

6. A method for identifying a compound which modulates the activity of a polypeptide consisting of the amino acid sequence of SEQ ID NO:5, the method comprising:

a) contacting a cell expressing the polypeptide with a test compound; and

b) determining the effect of the test compound on the activity of the polypeptide, thereby identifying a compound which modulates the activity of the polypeptide.

7. The method of claim 6 , wherein the activity is a hVR-2 activity.

8. The method of claim 7 , wherein the hVR-2 activity is modulation of membrane depolarization.

9. The method of claim 7 , wherein the hVR-2 activity is modulation of intracellular calcium levels.

10. The method of claim 6 , wherein the cell expressing the polypeptide is a neuronal cell.

11. A method for identifying a compound which modulates the activity of a polypeptide comprising the amino acid sequence of SEQ ID NO:5, the method comprising:

a)contacting a sample comprising the polypeptide with a test compound; and

b)determining the effect of the test compound on the activity of the polypeptide, thereby identifying a compound which modulates the activity of the polypeptide.

12. The method of claim 11 , wherein the sample comprises an isolated polypeptide or a membrane-bound form of an isolated polypeptide.

13. The method of claim 11 , wherein the activity is a hVR-2 activity.

14. The method of claim 13 , wherein the hVR-2 activity is modulation of membrane depolarization.

15. The method of claim 13 , wherein the hVR-2 activity is modulation of intracellular calcium levels.

16. A method for identifying a compound which modulates the activity of a polypeptide consisting of the amino acid sequence of SEQ ID NO:5, the method comprising:

a)contacting a sample comprising the polypeptide with a test compound; and

b)determining the effect of the test compound on the activity of the polypeptide, thereby identifying a compound which modulates the activity of the polypeptide.

17. The method of claim 16 , wherein the sample comprises an isolated polypeptide or a membrane-bound form of an isolated polypeptide.

18. The method of claim 16 , wherein the activity is a hVR-2 activity.

19. The method of claim 18 , wherein the hVR-2 activity is modulation of membrane depolarization.

20. The method of claim 18 , wherein the hVR-2 activity is modulation of intracellular calcium levels.

Assignments (2)
MERGER Recorded Feb 19, 2009
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AG
Reel/Frame 022277/0324 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2007
From: MILLENNIUM PHARMACEUTICALS, INC.
To: BAYER HEALTHCARE AG
Reel/Frame 019690/0014 →